[ RadSafe ] This "radiation journal" that probably doesn't exist

[Steven Dapra]

April 24

         Bjorn didn't use the word "thymidne" [sic], so what you, CB, 
"think" about it is "not relevant."

Steven Dapra


At 09:35 AM 4/24/2011, you wrote:

>I dont think you are correct about the labelled thymidne and the 
>incorporated Auger experments. The Baverstock Auger book shows many 
>orders of magnitude excess effect for DNA incorporated Auger 
>nuclides. And as for Tritium, since the track lengths are so short, 
>the fact that the RBE is 1 or 2 for HTO means that the H3 bound to 
>or very close to the DNA must have an alarming RBE to compensate for 
>the lost ionisation in the cytoplamic HTO. How do you explain that one?
>C
>
>-----Original Message-----
>From: radsafe-bounces at agni.phys.iit.edu on behalf of Bjorn Cedervall
>Sent: Sat 23/04/2011 10:34
>To: RadSafers Forum; radsafe at agni.phys.iit.edu
>Subject: Re: [ RadSafe ] This "radiation journal" that probably doesn't exist
>
>
>Another factor was your publications. I found around 14 papers in 
>PubMed and if I recall correctly none was in any of the major 
>journals for radiation biology, radiation physics or radiation 
>protection and some publications were actually letters. Many of the 
>other publications you have - I  interpret them as not being peer 
>reviewed. The eight publications in the "EBAB journal" fall outside 
>the approx. 14 PubMed publications as the EBAB status this far seems unclear.
>
>I should add however that I am interested in the scientific issues. 
>For instance the DNA-uranium discussion I saw somewhere 
>(references?). Another issue relating to radionuclides inside the 
>cell. Iodine 125 for instance incorportated into DNA has a DSB yield 
>that seems to just slightly higher than 1.0. These breaks match 
>Poisson distribution almost perfectly. My own experience with 
>tritium labeled DNA (for fragment analysis following X-ray exposure) 
>also matched a Poisson distribution. In both these cases the breaks 
>reflect a linear induction of DSBs as a function of dose. I will 
>come back to the leukemias.
>
>My personal initiative only,
>
>Bjorn Cedervall

[edit]